Problems of managing competitive development of the pharmaceutical market

The relevance of the topic lies in the fact that the pharmaceutical industry of Ukraine is one of the fastest growing and most crisis-resistant consumer industries in the economy. The main driver of growth is import substitution, which creates convincing arguments for international pharmaceutical companies to increase investments by acquiring existing players or setting up their own production facilities in Ukraine. The pharmaceutical industry development strategy envisages further harmonisation with European legislation, encouragement of investments in the development of local production of medicines and the development of new technologies, clinical trials, and digitalisation in Ukraine. After obtaining the candidate status to the European Union, the country expects to win, receive a large number of investments, and become part of the integrated supply and production chains of medicines.